| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 6.77e-06 | 12 | 64 | 3 | GO:0001851 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 3.03e-05 | 3 | 64 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 3.03e-05 | 3 | 64 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | X11-like protein binding | 3.03e-05 | 3 | 64 | 2 | GO:0042988 | |
| GeneOntologyMolecularFunction | opsonin binding | 6.87e-05 | 25 | 64 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 1.01e-04 | 5 | 64 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | complement binding | 1.46e-04 | 32 | 64 | 3 | GO:0001848 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 5.86e-04 | 51 | 64 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 5.97e-04 | 120 | 64 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 7.71e-04 | 13 | 64 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 1.18e-03 | 16 | 64 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 1.33e-03 | 17 | 64 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 1.33e-03 | 17 | 64 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 1.50e-03 | 18 | 64 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.58e-03 | 156 | 64 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 1.85e-03 | 20 | 64 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.52e-03 | 430 | 64 | 6 | GO:0004175 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 2.46e-07 | 207 | 64 | 8 | GO:1990138 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 3.43e-07 | 299 | 64 | 9 | GO:0060560 | |
| GeneOntologyBiologicalProcess | complement activation | 2.54e-06 | 70 | 64 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 4.08e-06 | 301 | 64 | 8 | GO:0048588 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse assembly | 1.26e-05 | 15 | 64 | 3 | GO:0051964 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.48e-05 | 187 | 64 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse organization | 3.64e-05 | 21 | 64 | 3 | GO:1905809 | |
| GeneOntologyBiologicalProcess | synapse organization | CLSTN3 NRCAM NCAN SLIT1 ROBO1 CLSTN2 FGFR2 CSMD2 UNC13A PTPRT | 4.58e-05 | 685 | 64 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 5.13e-05 | 313 | 64 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 5.50e-05 | 24 | 64 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 7.50e-05 | 228 | 64 | 6 | GO:0043393 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 9.42e-05 | 5 | 64 | 2 | GO:0018057 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BTN2A2 CLSTN3 NRCAM PTPRM MYO10 CD28 ROBO1 CLSTN2 ITGA4 CR1 PTPRT NCK2 | 1.02e-04 | 1077 | 64 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell growth | 1.27e-04 | 625 | 64 | 9 | GO:0016049 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.64e-04 | 377 | 64 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.66e-04 | 378 | 64 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CLSTN3 NRCAM PTPRM SLIT1 TRPV2 ROBO1 SEMA5A FGFR2 ITGA4 UNC13A | 1.69e-04 | 802 | 64 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.69e-04 | 379 | 64 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | cell junction organization | CLSTN3 NRCAM NCAN SLIT1 ROBO1 ACTN4 CLSTN2 FGFR2 CSMD2 UNC13A PTPRT | 1.84e-04 | 974 | 64 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.92e-04 | 387 | 64 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CLSTN3 NRCAM PTPRM SLIT1 TRPV2 ROBO1 SEMA5A FGFR2 ITGA4 UNC13A | 2.00e-04 | 819 | 64 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CLSTN3 NRCAM PTPRM SLIT1 TRPV2 ROBO1 SEMA5A FGFR2 ITGA4 UNC13A | 2.14e-04 | 826 | 64 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.18e-04 | 395 | 64 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CLSTN3 SIDT2 NRCAM PTPRM MYO10 SLIT1 TRPV2 ROBO1 SEMA5A FGFR2 ITGA4 UNC13A | 2.68e-04 | 1194 | 64 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 2.79e-04 | 41 | 64 | 3 | GO:1901889 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 3.07e-04 | 104 | 64 | 4 | GO:0030516 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 3.30e-04 | 106 | 64 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | axonogenesis | 3.51e-04 | 566 | 64 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | synapse assembly | 3.83e-04 | 308 | 64 | 6 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cytolysis by host of symbiont cells | 4.20e-04 | 10 | 64 | 2 | GO:0051838 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 4.20e-04 | 10 | 64 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 4.74e-04 | 49 | 64 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | humoral immune response | 4.76e-04 | 321 | 64 | 6 | GO:0006959 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension involved in axon guidance | 5.12e-04 | 11 | 64 | 2 | GO:0048843 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 5.12e-04 | 11 | 64 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 5.34e-04 | 51 | 64 | 3 | GO:0050919 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 5.63e-04 | 122 | 64 | 4 | GO:0061387 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 6.27e-04 | 618 | 64 | 8 | GO:0090066 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 6.31e-04 | 54 | 64 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 6.31e-04 | 54 | 64 | 3 | GO:0050922 | |
| GeneOntologyBiologicalProcess | activation of immune response | 6.61e-04 | 623 | 64 | 8 | GO:0002253 | |
| GeneOntologyBiologicalProcess | axon development | 8.03e-04 | 642 | 64 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | neuron recognition | 8.18e-04 | 59 | 64 | 3 | GO:0008038 | |
| GeneOntologyBiologicalProcess | axon extension | 8.23e-04 | 135 | 64 | 4 | GO:0048675 | |
| GeneOntologyBiologicalProcess | protein oxidation | 8.42e-04 | 14 | 64 | 2 | GO:0018158 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 8.42e-04 | 14 | 64 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 1.10e-03 | 519 | 64 | 7 | GO:0001558 | |
| GeneOntologyCellularComponent | cell surface | BTN2A2 CLSTN3 IGF2R NRCAM ADAMTS7 CD28 RTP2 TRPV2 ROBO1 CLSTN2 FGFR2 IDE ITGA4 CR1 IL3RA CTSS PTPRT | 3.16e-08 | 1111 | 65 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | extracellular matrix | A2M OLFML2A COL6A3 ADAMTS7 GLG1 LOX LOXL1 NCAN ADAMTS17 FGFR2 MUC5AC CTSS | 7.25e-07 | 656 | 65 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M OLFML2A COL6A3 ADAMTS7 GLG1 LOX LOXL1 NCAN ADAMTS17 FGFR2 MUC5AC CTSS | 7.49e-07 | 658 | 65 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.29e-04 | 157 | 65 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.30e-04 | 530 | 65 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.05e-04 | 201 | 65 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.12e-03 | 519 | 65 | 7 | GO:0009897 | |
| Domain | Sushi | 9.25e-07 | 52 | 64 | 5 | PF00084 | |
| Domain | CCP | 1.12e-06 | 54 | 64 | 5 | SM00032 | |
| Domain | SUSHI | 1.35e-06 | 56 | 64 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.47e-06 | 57 | 64 | 5 | IPR000436 | |
| Domain | Ig-like_fold | COL6A3 BTN2A2 NRCAM PTPRM IGHE CD28 NCAN ROBO1 LSAMP FGFR2 IL3RA PTPRT | 4.19e-06 | 706 | 64 | 12 | IPR013783 |
| Domain | IG_LIKE | 6.10e-06 | 491 | 64 | 10 | PS50835 | |
| Domain | Ig-like_dom | 7.54e-06 | 503 | 64 | 10 | IPR007110 | |
| Domain | ConA-like_dom | 9.76e-06 | 219 | 64 | 7 | IPR013320 | |
| Domain | SID1_TM_fam | 1.16e-05 | 2 | 64 | 2 | IPR025958 | |
| Domain | SID-1_RNA_chan | 1.16e-05 | 2 | 64 | 2 | PF13965 | |
| Domain | - | COL6A3 BTN2A2 NRCAM PTPRM CD28 NCAN ROBO1 LSAMP FGFR2 IL3RA PTPRT | 1.39e-05 | 663 | 64 | 11 | 2.60.40.10 |
| Domain | Calsyntenin | 3.46e-05 | 3 | 64 | 2 | IPR026914 | |
| Domain | FN3_dom | 7.98e-05 | 209 | 64 | 6 | IPR003961 | |
| Domain | IG | 9.15e-05 | 421 | 64 | 8 | SM00409 | |
| Domain | Ig_sub | 9.15e-05 | 421 | 64 | 8 | IPR003599 | |
| Domain | Lysyl_oxidase | 1.15e-04 | 5 | 64 | 2 | IPR001695 | |
| Domain | LYSYL_OXIDASE | 1.15e-04 | 5 | 64 | 2 | PS00926 | |
| Domain | Lysyl_oxidase_CS | 1.15e-04 | 5 | 64 | 2 | IPR019828 | |
| Domain | Lysyl_oxidase | 1.15e-04 | 5 | 64 | 2 | PF01186 | |
| Domain | - | 3.16e-04 | 95 | 64 | 4 | 2.60.120.200 | |
| Domain | FN3 | 4.29e-04 | 185 | 64 | 5 | SM00060 | |
| Domain | FN3 | 5.98e-04 | 199 | 64 | 5 | PS50853 | |
| Domain | TSP_1 | 1.32e-03 | 63 | 64 | 3 | PF00090 | |
| Domain | MAM_1 | 1.34e-03 | 16 | 64 | 2 | PS00740 | |
| Domain | TSP1 | 1.44e-03 | 65 | 64 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.44e-03 | 65 | 64 | 3 | IPR000884 | |
| Domain | TSP1 | 1.44e-03 | 65 | 64 | 3 | PS50092 | |
| Domain | MAM | 1.52e-03 | 17 | 64 | 2 | SM00137 | |
| Domain | MAM | 1.71e-03 | 18 | 64 | 2 | PF00629 | |
| Domain | MAM_dom | 1.71e-03 | 18 | 64 | 2 | IPR000998 | |
| Domain | MAM_2 | 1.71e-03 | 18 | 64 | 2 | PS50060 | |
| Domain | CTCK_1 | 1.71e-03 | 18 | 64 | 2 | PS01185 | |
| Domain | PLAC | 1.90e-03 | 19 | 64 | 2 | PS50900 | |
| Domain | PLAC | 1.90e-03 | 19 | 64 | 2 | IPR010909 | |
| Domain | IGv | 2.17e-03 | 75 | 64 | 3 | SM00406 | |
| Domain | fn3 | 2.31e-03 | 162 | 64 | 4 | PF00041 | |
| Domain | CT | 2.55e-03 | 22 | 64 | 2 | SM00041 | |
| Domain | MetalloPept_cat_dom | 2.71e-03 | 81 | 64 | 3 | IPR024079 | |
| Domain | - | 2.71e-03 | 81 | 64 | 3 | 3.40.390.10 | |
| Domain | ADAM_spacer1 | 2.79e-03 | 23 | 64 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.79e-03 | 23 | 64 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.04e-03 | 24 | 64 | 2 | IPR013273 | |
| Domain | TYR_PHOSPHATASE_1 | 3.21e-03 | 86 | 64 | 3 | PS00383 | |
| Domain | Cys_knot_C | 3.30e-03 | 25 | 64 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.30e-03 | 25 | 64 | 2 | PS01225 | |
| Domain | TYR_PHOSPHATASE_2 | 3.31e-03 | 87 | 64 | 3 | PS50056 | |
| Domain | PHD | 3.53e-03 | 89 | 64 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.76e-03 | 91 | 64 | 3 | IPR001965 | |
| Domain | HECT | 3.84e-03 | 27 | 64 | 2 | PF00632 | |
| Domain | HECTc | 3.84e-03 | 27 | 64 | 2 | SM00119 | |
| Domain | HECT_dom | 3.84e-03 | 27 | 64 | 2 | IPR000569 | |
| Domain | HECT | 3.84e-03 | 27 | 64 | 2 | PS50237 | |
| Domain | Ig_I-set | 4.10e-03 | 190 | 64 | 4 | IPR013098 | |
| Domain | I-set | 4.10e-03 | 190 | 64 | 4 | PF07679 | |
| Domain | ZF_PHD_2 | 4.24e-03 | 95 | 64 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.37e-03 | 96 | 64 | 3 | PS01359 | |
| Domain | ZINC_PROTEASE | 4.63e-03 | 98 | 64 | 3 | PS00142 | |
| Domain | Prot-tyrosine_phosphatase-like | 4.76e-03 | 99 | 64 | 3 | IPR029021 | |
| Domain | Ig_V-set | 4.83e-03 | 199 | 64 | 4 | IPR013106 | |
| Domain | PTPc | 6.76e-03 | 36 | 64 | 2 | SM00194 | |
| Domain | LAM_G_DOMAIN | 7.51e-03 | 38 | 64 | 2 | PS50025 | |
| Domain | Peptidase_M12B_N | 7.89e-03 | 39 | 64 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 7.89e-03 | 39 | 64 | 2 | PF01562 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.89e-03 | 39 | 64 | 2 | PS50055 | |
| Domain | DISINTEGRIN_1 | 8.29e-03 | 40 | 64 | 2 | PS00427 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.52e-05 | 143 | 53 | 6 | M27275 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.61e-05 | 50 | 53 | 4 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.93e-05 | 61 | 53 | 4 | M27103 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.21e-04 | 68 | 53 | 4 | M27303 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.23e-04 | 300 | 53 | 7 | M610 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.38e-04 | 133 | 53 | 5 | M16476 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.87e-04 | 76 | 53 | 4 | MM14573 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 2.06e-04 | 6 | 53 | 2 | M47880 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.35e-04 | 250 | 53 | 6 | M27554 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.58e-04 | 90 | 53 | 4 | M631 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.96e-04 | 258 | 53 | 6 | MM14572 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.17e-04 | 39 | 53 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.17e-04 | 39 | 53 | 3 | MM15165 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 5.96e-04 | 44 | 53 | 3 | M875 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 6.12e-04 | 10 | 53 | 2 | M27348 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.40e-04 | 109 | 53 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.92e-04 | 111 | 53 | 4 | M27416 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.05e-03 | 13 | 53 | 2 | M6322 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.28e-03 | 575 | 53 | 8 | M29853 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.39e-03 | 129 | 53 | 4 | M5539 | |
| Pubmed | The adaptor protein Nck2 mediates Slit1-induced changes in cortical neuron morphology. | 2.49e-08 | 4 | 65 | 3 | 21600986 | |
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 2.81e-06 | 52 | 65 | 4 | 30389913 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 32636836 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 15609098 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26804196 | ||
| Pubmed | Molecular cloning of a human serum protein structurally related to complement factor H. | 3.44e-06 | 2 | 65 | 2 | 1711047 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 38466882 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 33651882 | ||
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 3.44e-06 | 2 | 65 | 2 | 28785058 | |
| Pubmed | A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase. | 3.44e-06 | 2 | 65 | 2 | 7706256 | |
| Pubmed | Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. | 3.44e-06 | 2 | 65 | 2 | 12577300 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26067272 | ||
| Pubmed | 7.70e-06 | 251 | 65 | 6 | 29031500 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 16251195 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 34673103 | ||
| Pubmed | The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. | 1.03e-05 | 3 | 65 | 2 | 23494965 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 12498782 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 25988230 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 27116380 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 31273197 | ||
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 1.03e-05 | 3 | 65 | 2 | 17062560 | |
| Pubmed | ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. | 1.03e-05 | 3 | 65 | 2 | 30504844 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30890638 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 28965583 | ||
| Pubmed | C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. | 1.03e-05 | 3 | 65 | 2 | 23728178 | |
| Pubmed | 1.97e-05 | 28 | 65 | 3 | 18617019 | ||
| Pubmed | Differential expression of the LOX family genes in human colorectal adenocarcinomas. | 2.06e-05 | 4 | 65 | 2 | 19724858 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 24333077 | ||
| Pubmed | Upregulated copper transporters in hypoxia-induced pulmonary hypertension. | 2.06e-05 | 4 | 65 | 2 | 24614111 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 23589618 | ||
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 2.06e-05 | 4 | 65 | 2 | 27770832 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 18485748 | ||
| Pubmed | Lysyl oxidases: a novel multifunctional amine oxidase family. | 2.06e-05 | 4 | 65 | 2 | 11642359 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 10433822 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 25118846 | ||
| Pubmed | Expression patterns of Slit and Robo family members during vertebrate limb development. | 2.06e-05 | 4 | 65 | 2 | 11472852 | |
| Pubmed | 2.52e-05 | 90 | 65 | 4 | 15033168 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 12609596 | ||
| Pubmed | Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | 3.43e-05 | 5 | 65 | 2 | 8172644 | |
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 3.43e-05 | 5 | 65 | 2 | 25979655 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 15084255 | ||
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 3.43e-05 | 5 | 65 | 2 | 1689298 | |
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 3.43e-05 | 5 | 65 | 2 | 12954717 | |
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.43e-05 | 5 | 65 | 2 | 9771645 | |
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 3.43e-05 | 5 | 65 | 2 | 15207848 | |
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 3.43e-05 | 5 | 65 | 2 | 10380701 | |
| Pubmed | Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. | 3.43e-05 | 5 | 65 | 2 | 25894826 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 28234971 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21740577 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 11520671 | ||
| Pubmed | Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. | 3.43e-05 | 5 | 65 | 2 | 21118670 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 22772332 | ||
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 3.43e-05 | 5 | 65 | 2 | 11748139 | |
| Pubmed | 4.20e-05 | 205 | 65 | 5 | 20436479 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 12972431 | ||
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 5.13e-05 | 6 | 65 | 2 | 18829537 | |
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 5.13e-05 | 6 | 65 | 2 | 23487775 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 10864954 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 27196323 | ||
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 5.13e-05 | 6 | 65 | 2 | 22306607 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 5.13e-05 | 6 | 65 | 2 | 23161783 | |
| Pubmed | Slit antagonizes netrin-1 attractive effects during the migration of inferior olivary neurons. | 5.13e-05 | 6 | 65 | 2 | 12051827 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 18054781 | ||
| Pubmed | Robo1 and robo2 control the development of the lateral olfactory tract. | 5.13e-05 | 6 | 65 | 2 | 17360927 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 5.13e-05 | 6 | 65 | 2 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 5.13e-05 | 6 | 65 | 2 | 34249921 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 17438673 | ||
| Pubmed | 5.86e-05 | 40 | 65 | 3 | 36843585 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 21688288 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 7.18e-05 | 7 | 65 | 2 | 25490618 | |
| Pubmed | FLRT3 is a Robo1-interacting protein that determines Netrin-1 attraction in developing axons. | 7.18e-05 | 7 | 65 | 2 | 24560577 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 15037614 | ||
| Pubmed | 7.40e-05 | 376 | 65 | 6 | 24154525 | ||
| Pubmed | 9.37e-05 | 126 | 65 | 4 | 16284245 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 23884932 | ||
| Pubmed | Robos and slits control the pathfinding and targeting of mouse olfactory sensory axons. | 9.56e-05 | 8 | 65 | 2 | 18417704 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 9.56e-05 | 8 | 65 | 2 | 15091338 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 15162513 | ||
| Pubmed | Motor axons are guided to exit points in the spinal cord by Slit and Netrin signals. | 9.56e-05 | 8 | 65 | 2 | 28986144 | |
| Pubmed | Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. | 9.56e-05 | 8 | 65 | 2 | 17392456 | |
| Pubmed | Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | 9.56e-05 | 8 | 65 | 2 | 19458888 | |
| Pubmed | Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization. | 9.56e-05 | 8 | 65 | 2 | 26659946 | |
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 9.56e-05 | 8 | 65 | 2 | 22349628 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 27339457 | ||
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 9.56e-05 | 8 | 65 | 2 | 25485759 | |
| Pubmed | Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. | 9.56e-05 | 8 | 65 | 2 | 22912413 | |
| Pubmed | 1.22e-04 | 257 | 65 | 5 | 16335952 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 10864955 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 25056828 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 22806432 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 20059470 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 26954549 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 1.23e-04 | 9 | 65 | 2 | 20631173 | |
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 1.52e-04 | 55 | 65 | 3 | 32561725 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 21307234 | ||
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 23357697 | ||
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 31356769 | ||
| Pubmed | 1.61e-04 | 56 | 65 | 3 | 37059927 | ||
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.95e-07 | 57 | 50 | 5 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.07e-05 | 161 | 50 | 5 | 593 | |
| GeneFamily | Complement system|Sushi domain containing | 1.33e-04 | 36 | 50 | 3 | 492 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.29e-04 | 394 | 50 | 6 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 9.91e-04 | 160 | 50 | 4 | 555 | |
| GeneFamily | Cadherin related | 9.93e-04 | 17 | 50 | 2 | 24 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.24e-03 | 19 | 50 | 2 | 50 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.52e-03 | 21 | 50 | 2 | 813 | |
| GeneFamily | PHD finger proteins | 1.97e-03 | 90 | 50 | 3 | 88 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.03e-02 | 163 | 50 | 3 | 590 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.60e-06 | 35 | 64 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.80e-06 | 36 | 64 | 4 | MM1212 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP | 8.97e-06 | 198 | 64 | 6 | M4283 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | A2M CFHR1 OLFML2A PTPRM SIDT1 TRPV2 KCNMB1 SEMA5A ITGA4 NCK2 | 2.14e-05 | 795 | 64 | 10 | M39050 |
| Coexpression | NABA_ECM_REGULATORS | 2.54e-05 | 238 | 64 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.79e-05 | 242 | 64 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME | A2M COL6A3 ADAMTS7 LOX LOXL1 NCAN SLIT1 ADAMTS17 SEMA5A MUC5AC CTSS | 2.96e-05 | 1008 | 64 | 11 | MM17056 |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_6 | 3.47e-05 | 26 | 64 | 3 | M1202 | |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_6 | 3.47e-05 | 26 | 64 | 3 | MM523 | |
| Coexpression | NABA_MATRISOME | A2M COL6A3 ADAMTS7 LOX LOXL1 NCAN SLIT1 ADAMTS17 SEMA5A MUC5AC CTSS | 3.48e-05 | 1026 | 64 | 11 | M5889 |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 5.94e-05 | 31 | 64 | 3 | M18395 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 8.09e-05 | 427 | 64 | 7 | M17923 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 1.03e-04 | 444 | 64 | 7 | MM1051 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 1.23e-04 | 790 | 64 | 9 | M12490 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.24e-04 | 198 | 64 | 5 | M5419 | |
| Coexpression | GSE3982_BCELL_VS_TH1_UP | 1.27e-04 | 199 | 64 | 5 | M5551 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 1.27e-04 | 199 | 64 | 5 | M4494 | |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP | 1.30e-04 | 200 | 64 | 5 | M7742 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 1.30e-04 | 200 | 64 | 5 | M7027 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_16H_BMDC_UP | 1.30e-04 | 200 | 64 | 5 | M3818 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 1.76e-04 | 114 | 64 | 4 | M41678 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.19e-04 | 352 | 64 | 6 | M17471 | |
| Coexpression | KRAS.50_UP.V1_UP | 2.22e-04 | 48 | 64 | 3 | M2878 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M OLFML2A MTMR12 IGF2R DHRS3 PTPRM MYO10 ACTN4 FGFR2 CTSS NCK2 | 2.41e-04 | 1276 | 64 | 11 | M39173 |
| Coexpression | WESTON_VEGFA_TARGETS_6HR | 2.51e-04 | 50 | 64 | 3 | M1521 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | COL6A3 CLSTN3 NRCAM MYO10 LOXL1 NCAN ADAMTS17 NINL CLSTN2 FGFR2 MCM10 CTSS SP140 | 3.18e-06 | 976 | 61 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.39e-05 | 51 | 61 | 4 | gudmap_developingGonad_P2_testes_1000_k5 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | CFHR2 COL6A3 DHRS3 MYO10 KCNMB1 SEMA5A ACTN4 FGFR2 ITGA4 CTSS SP140 | 2.43e-05 | 842 | 61 | 11 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 4.19e-05 | 734 | 61 | 10 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_200 | 1.16e-04 | 33 | 61 | 3 | gudmap_developingGonad_P2_epididymis_200_k5 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.13e-08 | 188 | 65 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-08 | 188 | 65 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.30e-08 | 192 | 65 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.45e-08 | 195 | 65 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-07 | 184 | 65 | 6 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-07 | 187 | 65 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-07 | 189 | 65 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-07 | 190 | 65 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-07 | 191 | 65 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-07 | 192 | 65 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-07 | 192 | 65 | 6 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-07 | 192 | 65 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-07 | 193 | 65 | 6 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-07 | 193 | 65 | 6 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-07 | 193 | 65 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.86e-07 | 193 | 65 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.98e-07 | 194 | 65 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-07 | 194 | 65 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-07 | 196 | 65 | 6 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-07 | 196 | 65 | 6 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.35e-07 | 197 | 65 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.48e-07 | 198 | 65 | 6 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.62e-07 | 199 | 65 | 6 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.75e-07 | 200 | 65 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 4.75e-07 | 200 | 65 | 6 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-06 | 163 | 65 | 5 | 9c91415a56b12b3b2d15d253bb59db8bedf49ea2 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.07e-06 | 163 | 65 | 5 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.07e-06 | 163 | 65 | 5 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 170 | 65 | 5 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-06 | 173 | 65 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-06 | 174 | 65 | 5 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.24e-06 | 178 | 65 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.42e-06 | 179 | 65 | 5 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.42e-06 | 179 | 65 | 5 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-06 | 180 | 65 | 5 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-06 | 181 | 65 | 5 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.77e-06 | 181 | 65 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 182 | 65 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 182 | 65 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 184 | 65 | 5 | 5cf7447faaec99fc37dfa8e92ff72cc2c7c05951 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 184 | 65 | 5 | 7126261a453c7e2f3f005016873b6adeb51e46f8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-06 | 184 | 65 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 185 | 65 | 5 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 185 | 65 | 5 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-06 | 185 | 65 | 5 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.93e-06 | 187 | 65 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-06 | 187 | 65 | 5 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-06 | 187 | 65 | 5 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-06 | 187 | 65 | 5 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.93e-06 | 187 | 65 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-06 | 187 | 65 | 5 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 7.93e-06 | 187 | 65 | 5 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-06 | 187 | 65 | 5 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-06 | 187 | 65 | 5 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.93e-06 | 187 | 65 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.93e-06 | 187 | 65 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 188 | 65 | 5 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 188 | 65 | 5 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 8.14e-06 | 188 | 65 | 5 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.14e-06 | 188 | 65 | 5 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.35e-06 | 189 | 65 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-06 | 189 | 65 | 5 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-06 | 189 | 65 | 5 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.35e-06 | 189 | 65 | 5 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-06 | 189 | 65 | 5 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 8.35e-06 | 189 | 65 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.35e-06 | 189 | 65 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 8.35e-06 | 189 | 65 | 5 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.35e-06 | 189 | 65 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.35e-06 | 189 | 65 | 5 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-06 | 190 | 65 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.57e-06 | 190 | 65 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-06 | 190 | 65 | 5 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.57e-06 | 190 | 65 | 5 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-06 | 190 | 65 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.57e-06 | 190 | 65 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.57e-06 | 190 | 65 | 5 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.57e-06 | 190 | 65 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 191 | 65 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.79e-06 | 191 | 65 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.79e-06 | 191 | 65 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 191 | 65 | 5 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.79e-06 | 191 | 65 | 5 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-06 | 191 | 65 | 5 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.79e-06 | 191 | 65 | 5 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.79e-06 | 191 | 65 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 192 | 65 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-06 | 192 | 65 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 192 | 65 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.01e-06 | 192 | 65 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-06 | 192 | 65 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 192 | 65 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.01e-06 | 192 | 65 | 5 | 905217dcfc843d3469e9e71bd33707863b14cc82 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 193 | 65 | 5 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 193 | 65 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-06 | 193 | 65 | 5 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| Drug | Z-Gly-phe-NH2 | 5.94e-06 | 13 | 64 | 3 | CID000096819 | |
| Drug | Bacitracin | 7.78e-06 | 2 | 64 | 2 | DB00626 | |
| Drug | desmosine | 1.50e-05 | 53 | 64 | 4 | CID000025435 | |
| Drug | chondroitin sulfate | 2.00e-05 | 413 | 64 | 8 | CID000024766 | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 5449_UP | |
| Drug | Linuron | 3.04e-05 | 128 | 64 | 5 | ctd:D008044 | |
| Drug | enzacamene | 3.15e-05 | 129 | 64 | 5 | ctd:C038939 | |
| Drug | Vitamin K 3 | A2M SIDT2 IGF2R PTPRM MYO10 GLG1 LOX KDM2B ROBO1 PUM3 G2E3 FGFR2 ITGA4 | 3.67e-05 | 1249 | 64 | 13 | ctd:D024483 |
| Disease | multiple sclerosis | 5.25e-06 | 594 | 64 | 9 | MONDO_0005301 | |
| Disease | galectin-4 measurement | 2.77e-05 | 4 | 64 | 2 | EFO_0020398 | |
| Disease | complement factor H-related protein 2 measurement | 3.42e-05 | 29 | 64 | 3 | EFO_0600055 | |
| Disease | descending aortic diameter | 4.09e-05 | 88 | 64 | 4 | EFO_0021788 | |
| Disease | spermidine measurement | 4.61e-05 | 5 | 64 | 2 | EFO_0021802 | |
| Disease | Acute Confusional Senile Dementia | 6.49e-05 | 99 | 64 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 6.49e-05 | 99 | 64 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 6.49e-05 | 99 | 64 | 4 | C0750901 | |
| Disease | Presenile dementia | 6.49e-05 | 99 | 64 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 6.49e-05 | 99 | 64 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 6.75e-05 | 100 | 64 | 4 | C0276496 | |
| Disease | glycerophosphocholine measurement | 6.91e-05 | 6 | 64 | 2 | EFO_0010489 | |
| Disease | Alzheimer's Disease | 7.02e-05 | 101 | 64 | 4 | C0002395 | |
| Disease | Liver Cirrhosis | 7.57e-05 | 103 | 64 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 8.16e-05 | 105 | 64 | 4 | C0239946 | |
| Disease | bipolar II disorder | 1.29e-04 | 8 | 64 | 2 | EFO_0009964 | |
| Disease | disease recurrence, malaria | 1.29e-04 | 8 | 64 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | survival time | 1.65e-04 | 9 | 64 | 2 | EFO_0000714 | |
| Disease | C3 glomerulopathy | 1.65e-04 | 9 | 64 | 2 | C4087273 | |
| Disease | aortic measurement | 2.17e-04 | 251 | 64 | 5 | EFO_0020865 | |
| Disease | Malignant neoplasm of lung | 2.83e-04 | 266 | 64 | 5 | C0242379 | |
| Disease | alcoholic liver disease | 7.63e-04 | 82 | 64 | 3 | EFO_0008573 | |
| Disease | response to anticonvulsant | 8.47e-04 | 85 | 64 | 3 | GO_0036277 | |
| Disease | colorectal health | 9.65e-04 | 201 | 64 | 4 | EFO_0008460 | |
| Disease | Hepatolenticular Degeneration | 1.24e-03 | 24 | 64 | 2 | C0019202 | |
| Disease | Hepatic Form of Wilson Disease | 1.24e-03 | 24 | 64 | 2 | C1527352 | |
| Disease | Nephrotic Syndrome | 1.57e-03 | 27 | 64 | 2 | C0027726 | |
| Disease | triacylglycerol 56:7 measurement | 1.81e-03 | 29 | 64 | 2 | EFO_0010434 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement | 1.81e-03 | 29 | 64 | 2 | EFO_0004735, EFO_0004736 | |
| Disease | Age related macular degeneration | 1.94e-03 | 30 | 64 | 2 | C0242383 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IFNNCHELYSREYQT | 1011 | Q9UPW8 | |
| YATNSAEVCQYVITH | 136 | Q5FVE4 | |
| TTKCVRQYEGHVNEY | 401 | Q8WV16 | |
| VCLESEGRYYNAHIQ | 501 | Q9NP73 | |
| TRAVTHNEQLCYQLY | 361 | Q9NR81 | |
| IVCNTVQNEDGFSHY | 396 | Q9BQT9 | |
| VNYNNNHECIYSIQT | 1116 | Q7Z408 | |
| SAVEVCVVYGNYSQQ | 61 | P10747 | |
| NELDYYDSHNVNTRC | 481 | O43707 | |
| QHQYEILVTAYDCGQ | 226 | Q9H4D0 | |
| FQHREVTCVYQLQNG | 881 | Q8TE56 | |
| VLYDVSHQCRLQYGA | 466 | Q9UKP4 | |
| DCINRHNVYINGITY | 641 | P01023 | |
| YSQVHICLRSGNYQE | 326 | Q75QN2 | |
| AHDSTRVIQCYIQYG | 176 | Q15397 | |
| YHTEDTRDQNQQCSY | 91 | Q16558 | |
| CVVENEYGSINHTYH | 231 | P21802 | |
| YYGNVTRHQAECALN | 286 | O43639 | |
| YICYARFNHTQTIQQ | 216 | Q92823 | |
| YVQEDSCQHGVYGRL | 61 | Q9C0I1 | |
| LYLACQEGHLEVTQY | 176 | B1AK53 | |
| NVVRCNIHYTGRYVS | 551 | Q08397 | |
| DIQIVQVACGYYHSL | 136 | Q5GLZ8 | |
| GSSVEYQCQNLYQLE | 171 | P36980 | |
| YHYLNQSGCVEDKTI | 286 | Q9HD67 | |
| YQCRYEELRVTAGNH | 311 | Q9NSB4 | |
| TQTVNLRDCEYCQYH | 401 | Q7L590 | |
| YQNQSTCAVYHRSLI | 5526 | P98088 | |
| CQAHSQLLQYVERYG | 416 | Q96FC9 | |
| TQHFREQSECMIYQY | 641 | Q495T6 | |
| GYAVTRCHSYNLTVQ | 411 | O14522 | |
| NAYQELLQHYERCDV | 221 | Q7L622 | |
| DHRGNITEYQCHQYI | 206 | Q92896 | |
| RQQYECLHYKTDAQG | 146 | P26951 | |
| VYCVTQRSHLTQEYQ | 371 | Q8NHM5 | |
| NRENFHYGSVVTYRC | 181 | P17927 | |
| NRENFHYGSVVTYRC | 631 | P17927 | |
| NRENFHYGSVVTYRC | 1081 | P17927 | |
| DGVQQTTYLAQQYCH | 371 | Q5T2R2 | |
| GQTYHVAVVCYLRSQ | 3051 | P12111 | |
| LSDRTYTCQVTYQGH | 186 | P01854 | |
| YTNNVVRCDIRYTGH | 391 | P28300 | |
| QTTTGECHFENYQRV | 846 | P13612 | |
| VYYEPSCTQNVNHGV | 266 | P25774 | |
| QRNEVHNNCGIEIYY | 781 | P14735 | |
| SSVEYQCQNLYQLEG | 231 | Q03591 | |
| IHNVTAQENGIYRCY | 116 | Q8WVV5 | |
| IYEQSCEVYRHQGNT | 586 | Q8WYK1 | |
| HYFICDVGNREEVYQ | 91 | O75911 | |
| VCGILYAVDTYNQQE | 581 | Q68BL7 | |
| TVHYCYQVGGQEQVR | 416 | P28827 | |
| SLVHNGVSYYINLCQ | 2016 | P11717 | |
| REQCYEEDGGQYRIH | 126 | Q5QGT7 | |
| YQTVVNVTGNQDICY | 471 | Q8NBJ9 | |
| TVTNVTEEHYGNYTC | 276 | Q13449 | |
| VHATVRYQCNEGFAQ | 1236 | O14594 | |
| IYGVNQSQVQRYISC | 256 | Q8N695 | |
| CYHQELSYQQGQVEQ | 381 | Q9Y2I6 | |
| GLRYLHTQYCHQQTE | 461 | A0A1B0GV85 | |
| TYCQRYQQQSHDATV | 991 | Q13591 | |
| ATDCYIVHEIYNGEN | 26 | P17152 | |
| YQTVVNVTGNQDICY | 466 | Q9NXL6 | |
| LVNAQCTDDYYRGHS | 151 | Q9Y5S1 | |
| TNVQRSDVGYYICQT | 416 | Q9Y6N7 | |
| LNEIYRSFQNVCYEH | 126 | Q13342 | |
| YEALRNCHRNSQVYG | 266 | Q8IWY8 | |
| DFHQVQRGYAICQTT | 1466 | O75093 |